Floridian Research Institute

Recent papers from Floridian Research Institute

1. Ghost Rates Under the No Surprises Act: How Insurer Calculations Artificially Lower the Qualifying Payment AmountCureus · 2026
2. Follow the Cuts in American Healthcare From 2001 to 2026: A Three-Ledger Analysis of Scrutiny–Control Inversion, Payment Restraint, Revenue Capture, and Official BlameCureus · 2026
3. A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants with End‐Stage Kidney Disease on HemodialysisThe Journal of Clinical Pharmacology · 2026
4. A Proof‐of‐Concept Phase 2a Partly Randomised Study Evaluating Leronlimab in Patients With Presumed Non‐Cirrhotic Metabolic Dysfunction–Associated SteatohepatitisLiver international communications. · 2025
5. Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open‐label extension studyJournal of the European Academy of Dermatology and Venereology · 2025
6. Picophytoplankton Implicated in Productivity and Biogeochemistry in the North Pacific Transition Zone2025
7. Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): A Randomized, Double-Blind, Placebo-Controlled TrialJAIDS Journal of Acquired Immune Deficiency Syndromes · 2025